Outputs (2)

Mapping brain endophenotypes associated with idiopathic pulmonary fibrosis genetic risk (2022)
Journal Article
Mohammadi-Nejad, A. R., Allen, R. J., Kraven, L. M., Leavy, O. C., Jenkins, R. G., Wain, L. V., …Sotiropoulos, S. N. (2022). Mapping brain endophenotypes associated with idiopathic pulmonary fibrosis genetic risk. EBioMedicine, 86, Article 104356. https://doi.org/10.1016/j.ebiom.2022.104356

Background: Idiopathic pulmonary fibrosis (IPF) is a serious disease of the lung parenchyma. It has a known polygenetic risk, with at least seventeen regions of the genome implicated to date. Growing evidence suggests linked multimorbidity of IPF wit... Read More about Mapping brain endophenotypes associated with idiopathic pulmonary fibrosis genetic risk.

Anticholinergic drugs and forebrain magnetic resonance imaging changes in cognitively normal people and those with mild cognitive impairment (2022)
Journal Article
Meng, D., Mohammadi-Nejad, A. R., Sotiropoulos, S. N., & Auer, D. P. (2022). Anticholinergic drugs and forebrain magnetic resonance imaging changes in cognitively normal people and those with mild cognitive impairment. European Journal of Neurology, https://doi.org/10.1111/ene.15251

Background and purpose: Anticholinergic (AC) medication use is associated with cognitive decline and dementia, which may be related to an AC-induced central hypocholinergic state, but the exact mechanisms remain to be understood. We aimed to further... Read More about Anticholinergic drugs and forebrain magnetic resonance imaging changes in cognitively normal people and those with mild cognitive impairment.